» Authors » Sushila R Dalal

Sushila R Dalal

Explore the profile of Sushila R Dalal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 499
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Runde J, Erondu A, Akiyama S, Traboulsi C, Rai V, Glick L, et al.
Inflamm Bowel Dis . 2022 Jan; 28(9):1386-1394. PMID: 35040964
Background: Despite significant differences in surgical outcomes between pediatric and adult patients with ulcerative colitis (UC) undergoing colectomy, counseling on pediatric outcomes has largely been guided by data from adults....
12.
Akiyama S, Yamada A, Ollech J, Komaki Y, Komaki F, Pekow J, et al.
J Gastroenterol Hepatol . 2021 May; 36(10):2785-2793. PMID: 33973282
Background And Aim: Approximately half of patients with Crohn's disease (CD) who have surgery will experience clinical recurrence within 10 years of their surgery. This study aimed to assess the...
13.
Akiyama S, Ollech J, Rai V, Glick L, Yi Y, Traboulsi C, et al.
Clin Gastroenterol Hepatol . 2021 Feb; 20(2):293-302.e9. PMID: 33549868
Background & Aims: Pouchitis is a common complication of ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis who have undergone colectomy. Pouchitis has been considered a single entity despite...
14.
Ollech J, Avni-Biron I, Glick L, Haider H, Dalal S, Micic D, et al.
Clin Gastroenterol Hepatol . 2020 Nov; 19(11):2444-2446.e2. PMID: 33223497
Data regarding the management and outcomes of acute severe ulcerative colitis (ASUC) in pregnant patients is sparse, consisting mainly of case reports. We report on the largest cohort of pregnant...
15.
Ollech J, Normatov I, Peleg N, Dalal S, Pekow J, Micic D, et al.
Int J Colorectal Dis . 2020 Jul; 35(11):2113-2116. PMID: 32710391
Introduction: In this study, we evaluate the efficacy and safety of the biosimilar infliximab, CT-P13, in the treatment of inpatients with severe steroid-refractory colitis. Methods: A retrospective cohort study of...
16.
Ollech J, Normatov I, Peleg N, Wang J, Patel S, Rai V, et al.
Clin Gastroenterol Hepatol . 2020 Feb; 19(1):104-110. PMID: 32109634
Background & Aims: A subset of patients with Crohn's disease (CD) do not respond to ustekinumab at the standard dose of 90 mg every 8 weeks. Little is known about...
17.
Ollech J, Dwadasi S, Rai V, Peleg N, Normatov I, Israel A, et al.
Aliment Pharmacol Ther . 2019 Dec; 51(6):637-643. PMID: 31875986
Background: Following induction therapy with a calcineurin inhibitor (CNI) in severe ulcerative colitis, transitioning to vedolizumab as maintenance therapy could be an option. Aim: To report on the largest cohort...
18.
Israel A, Christensen B, El Jurdi K, Rai V, Ollech J, Cohen R, et al.
Clin Gastroenterol Hepatol . 2019 Jun; 18(4):987-988.e1. PMID: 31228567
The natural history of ulcerative colitis (UC) follows a relapsing and remitting course of inflammation and is accompanied by associated mucosal injury and historically, microscopic features of chronicity that were...
19.
Ollech J, Rubin D, Glick L, Weisshof R, El Jurdi K, Israel A, et al.
Dig Dis Sci . 2019 Jun; 64(12):3596-3601. PMID: 31187322
Background: Chronic antibiotic-refractory pouchitis (CARP) occurs in up to 15% of patients with ulcerative colitis (UC) following proctocolectomy with ileal pouch-anal anastomosis (IPAA). Aim: To investigate the effectiveness of ustekinumab...
20.
Ollech J, Aharoni-Golan M, Weisshof R, Normatov I, Sapp A, Kalakonda A, et al.
Gastrointest Endosc . 2019 Feb; 90(2):269-275. PMID: 30738034
Background And Aims: It is standard of care to perform ileocolonoscopy within a year of ileocolonic resection for Crohn's disease (CD) and to guide management decisions based on the Rutgeert...